Nagpur
+919405117673
+919405117673

Relugolix 120mg Tablets: Revolutionizing Hormone Therapy for Advanced Prostate Cancer | Cordium Pharmaceuticals Pvt Ltd

Relugolix 120mg Tablets: A New Era in Oral Prostate Cancer Management

The global burden of prostate cancer is increasing rapidly, creating a greater demand for innovative, patient-friendly therapies. Relugolix 120mg Tablets represent a significant advancement in hormone therapy by offering a convenient oral alternative to traditional injectable treatments.

Cordium Pharmaceuticals Pvt Ltd is dedicated to delivering quality oncology solutions to healthcare providers, distributors, hospitals, and importers across Kenya, Nigeria, Ghana, Philippines, Vietnam, UAE, Saudi Arabia, Uzbekistan, Kazakhstan, USA, UK, and South Africa.

What Are Relugolix 120mg Tablets?

Relugolix is a prescription medication used to treat adult men with advanced prostate cancer.

It belongs to a class of medicines called gonadotropin-releasing hormone (GnRH) receptor antagonists, which work by lowering testosterone production. Since prostate cancer cells often depend on testosterone for growth, reducing hormone levels helps slow disease progression.


Why Is Relugolix Becoming a Preferred Treatment Worldwide?

Healthcare professionals are increasingly choosing Relugolix because it offers several advantages over conventional hormone therapies.

Key Clinical Advantages

✓ Oral Once-Daily Administration

No hospital visits for regular injections.

✓ Rapid Testosterone Suppression

Helps achieve effective androgen deprivation quickly.

✓ Improved Patient Compliance

Simple oral dosing encourages adherence.

✓ Faster Hormonal Recovery

Testosterone levels may recover faster after discontinuation.

✓ Reduced Treatment Burden

Supports outpatient cancer management.


Conditions Treated with Relugolix 120mg Tablets

Relugolix may be prescribed for:

  • Advanced prostate cancer
  • Metastatic prostate cancer
  • Hormone-sensitive prostate cancer
  • Long-term androgen deprivation therapy (ADT)

Treatment decisions should always be made by oncology specialists.


How Does Relugolix Work?

Relugolix blocks GnRH receptors located in the pituitary gland, leading to decreased production of:

  • Luteinizing hormone (LH)
  • Follicle-stimulating hormone (FSH)
  • Testosterone

By lowering testosterone levels, prostate cancer cell growth can be significantly reduced.


Recommended Dosing Information

Initial Dose

360 mg orally on the first day.

Maintenance Dose

120 mg orally once daily.

Administration Guidelines

  • Take at the same time every day.
  • Can be taken with or without food.
  • Swallow tablets whole with water.
  • Do not skip or double doses.

Always follow the prescribing physician's instructions.


Possible Side Effects

Patients may experience:

  • Hot flashes
  • Fatigue
  • Joint discomfort
  • Weight changes
  • Increased blood sugar levels
  • Muscle pain
  • Reduced sexual desire
  • Digestive discomfort

Consult a healthcare professional if symptoms become severe.


Growing Demand Across International Healthcare Markets

The demand for oral prostate cancer therapies is growing due to aging populations, improved cancer screening programs, and expanding access to oncology care.

Priority Export Markets

Africa

🇰🇪 Kenya

🇳🇬 Nigeria

🇬🇭 Ghana

🇿🇦 South Africa

Middle East

🇦🇪 UAE

🇸🇦 Saudi Arabia

Asia

🇵🇭 Philippines

🇻🇳 Vietnam

🇺🇿 Uzbekistan

🇰🇿 Kazakhstan

Europe & North America

🇬🇧 United Kingdom

🇺🇸 United States


Why Partner with Cordium Pharmaceuticals Pvt Ltd?

Cordium Pharmaceuticals Pvt Ltd is committed to supplying reliable, high-quality pharmaceutical products to international markets.

Our Strengths

✔ WHO-GMP compliant manufacturing

✔ Stringent quality assurance systems

✔ International export expertise

✔ Regulatory support documentation

✔ Stable global supply chain

✔ Timely order fulfillment

✔ Dedicated B2B partnerships


Frequently Asked Questions (SEO Rich Snippets)

Is Relugolix 120mg used for prostate cancer?

Yes. Relugolix is prescribed for adult men with advanced prostate cancer as part of hormone suppression therapy.

Is Relugolix an oral medicine?

Yes. It is a once-daily oral tablet.

Can Relugolix replace injectable hormone therapy?

In many cases, physicians may prescribe Relugolix as an oral alternative depending on individual patient needs.

Who supplies Relugolix internationally?

Cordium Pharmaceuticals Pvt Ltd supports global pharmaceutical supply partnerships in multiple international markets.

 2026-06-19T13:46:14

Other Pages

View all pages